Sodium Thiosulfate ( DrugBank: - )
2 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 50 | Dermatomyositis | 4 |
| 51 | Scleroderma | 2 |
50. Dermatomyositis
Clinical trials : 182 / Drugs : 229 - (DrugBank : 88) / Drug target genes : 48 - Drug target pathways : 147
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03582800 (ClinicalTrials.gov) | January 6, 2020 | 13/6/2018 | Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study | Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study | Systemic Sclerosis;Dermatomyositis;iPPSD2 | Drug: STS | University Hospital, Limoges | NULL | Recruiting | 6 Months | N/A | All | 40 | Phase 2 | France |
| 2 | EUCTR2018-001978-22-FR (EUCTR) | 31/07/2019 | 17/09/2018 | Injections of Sodium Thiosulfate for ectopic calcifications or ossifications. A pilot study. | Injections of Sodium Thiosulfate for ectopic calcifications or ossifications. A pilot study. - ITS Pilot | Patient presenting with: - ectopic ossification secondary to iPPSD2 or - ectopic calcification secondary to dermatomyositis or - ectopic calcification secondary to systemic sclerosis MedDRA version: 20.0;Level: LLT;Classification code 10006935;Term: Calcification and ossification, unspecified;System Organ Class: 100000004867 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17] | Trade Name: Sodium Thiosulfate 10% Product Name: Sodium thiosulfate INN or Proposed INN: Sodium thiosulfate 10% Other descriptive name: SODIUM THIOSULFATE PENTAHYDRATE | CHU de LIMOGES | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 40 | Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): no | France | ||
| 3 | NCT03267277 (ClinicalTrials.gov) | October 5, 2017 | 29/8/2017 | Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis | An Open-label Study of Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis | Dermatomyositis;Idiopathic Inflammatory Myopathies | Drug: Sodium Thiosulfate | National Institute of Environmental Health Sciences (NIEHS) | NULL | Recruiting | 7 Years | N/A | All | 250 | Phase 2/Phase 3 | United States |
| 4 | NCT01572844 (ClinicalTrials.gov) | August 2012 | 4/4/2012 | Topical Sodium Thiosulfate and Fractional Carbon Dioxide Laser in Treating Dermatomyositis Associated Calcinosis | Novel Drug Delivery of Sodium Thiosulfate for Calcinosis Associated With Adult and Juvenile Dermatomyositis | Calcinosis | Device: Fractionated Carbon Dioxide (FCO2) Laser;Drug: Sodium thiosulfate | Alison Ehrlich | NULL | Completed | 18 Years | 65 Years | All | 3 | Phase 2 | United States |
51. Scleroderma
Clinical trials : 523 / Drugs : 608 - (DrugBank : 156) / Drug target genes : 114 - Drug target pathways : 215
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03582800 (ClinicalTrials.gov) | January 6, 2020 | 13/6/2018 | Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study | Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study | Systemic Sclerosis;Dermatomyositis;iPPSD2 | Drug: STS | University Hospital, Limoges | NULL | Recruiting | 6 Months | N/A | All | 40 | Phase 2 | France |
| 2 | EUCTR2018-001978-22-FR (EUCTR) | 31/07/2019 | 17/09/2018 | Injections of Sodium Thiosulfate for ectopic calcifications or ossifications. A pilot study. | Injections of Sodium Thiosulfate for ectopic calcifications or ossifications. A pilot study. - ITS Pilot | Patient presenting with: - ectopic ossification secondary to iPPSD2 or - ectopic calcification secondary to dermatomyositis or - ectopic calcification secondary to systemic sclerosis MedDRA version: 20.0;Level: LLT;Classification code 10006935;Term: Calcification and ossification, unspecified;System Organ Class: 100000004867 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17] | Trade Name: Sodium Thiosulfate 10% Product Name: Sodium thiosulfate INN or Proposed INN: Sodium thiosulfate 10% Other descriptive name: SODIUM THIOSULFATE PENTAHYDRATE | CHU de LIMOGES | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 40 | Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): no | France |